Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-24T12:36:25.309Z Has data issue: false hasContentIssue false
  • English
  • Français

Tranquilización rápida: nuevos enfoques en el tratamiento de urgencias de las perturbaciones del comportamiento

Published online by Cambridge University Press:  12 May 2020

Jürgen De Fruyt  and
Koen Demyttenaerea
Jürgen De Fruyt
Affiliation:
Depammento de Psiquiatría, Hospital Universitario de Gasthuisberg, Merestraat 49, 3000Leuven, Bélgica Departamento de Psiquiatría, Hospital General de Sint-Jan av, AZ Sint-Jan AV, Ruddershove 10, 8000Brujas, Bélgica
Koen Demyttenaerea
Affiliation:
Depammento de Psiquiatría, Hospital Universitario de Gasthuisberg, Merestraat 49, 3000Leuven, Bélgica
Get access

Resumen

Las urgencias psiquiátricas se acompañan a menudo por perturbaciones del comportamiento que interfieren la evaluación normal y requieren intervención inmediata. Se han utilizado regímenes de tratamiento farmacológico diferentes para este propósito. La mayoría de estos regímenes se basan en la práctica clínica común y tienen una base probatoria limitada. Hace poco, una publicación importante de expertos en el campo de la psiquiatría de urgencias ha cubierto este asunto y se ha extendido el arsenal terapéutico con los antipsicóticos atípicos. Sin embargo, diferentes limitaciones metodológicas obstaculizan todavía la investigación: una definición poco clara del estado agitado y la meta terapéutica, la medición idiosincrasica y el pequeño tamaño de las muestras. La perspectiva del paciente y la interacción entre el entorno asistencial de urgencias y el regimen de tratamiento requieren también más atención. Todos estos aspectos importantes, pero olvidados a menudo, se cubren en una revisión selectiva de las publicaciones.

Keywords

Psiquiatría de urgenciasPsicosisAgitaciónViolenciaTranquilización rápidaSedación
Type
Revisión
Information
European Psychiatry (Ed. Española) , Volume 11 , Issue 8 , November 2004 , pp. 477 - 484
Copyright
Copyright © European Psychiatric Association 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

Agitation calmness scale. Eli Lilly and Company; 1998 Copyright.Google Scholar
Alien, MH.Level 1 psychiatric emergency services. The tools of the crisis sector. Psychiatr Clin North Am 1999;22:713–34.CrossRefGoogle Scholar
Alien, MH.Managing the agitated psychotic patient: a reappraisal of the evidence. J Clin Psychiatry 2000;61(Suppl 14): 11–61.Google Scholar
Alien, MH, Currier, GW, Hughes, DH, et al.The Expert Consensus Guideline Series: treatment of behavioral emergencias. Postgraduate Medicine Special Report 2001:1–90.Google Scholar
Atakan, Z, Davies, T.ABC of mental health. Mental health emergencies. BMJ 1997;314:1740–2.Google ScholarPubMed
Battaglia, J, Moss, S, Rush, J, Kang, J, Mendoza, R, Leedom, L, et al.Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Am J Emerg Med 1997;15:335–40.CrossRefGoogle ScholarPubMed
Bellnier, TJ.Continuum of care: stabilizing the acutely agitated patient. Am J Health-Syst Pharm 2002;59(Suppl 5): 12–59.CrossRefGoogle ScholarPubMed
Bieniek, SA, Ownby, RL, Penalver, A, Domínguez, RA.A doubleblind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Pharmacotherapy 1998;18:57–62.Google Scholar
Binder, RL, McNeil, DE.Contemporary practices in managing acutely violent patients in 20 psychiatric emergency rooms. Psychiatr Serv 1999;50:1553–4.CrossRefGoogle ScholarPubMed
Breier, A, Meehan, K, Birkett, M, David, S, Ferchland, , et al.A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry 2002;59:441–8.CrossRefGoogle Scholar
Breslow, RE, Klinger, BI, Erickson, BJ.Acute intoxication and substance abuse among patients presenting to a psychiatric emergency Service. Gen Hosp Psychiatry 1996;18:183–91.CrossRefGoogle ScholarPubMed
Broadstock, M.The effectiveness and safety of drug treatment for urgent sedation in psychiatric emergencias. A critical appraisal of the literature. N Z Health Technol Assess Clearing House Rep 2001; 4(1).Google Scholar
Brook, S, Lucey, JV, Gunn, KP, for the Ziprasidone IM Study Group. Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. J Clin Psychiatry 2000;61:933–41.CrossRefGoogle ScholarPubMed
Canas, F.Sustaining short-term gains for future progress. Int Clin Psychopharmacol 2001;16(Suppl 1):9–13.Google ScholarPubMed
Corrigan, JD.Development of a scale for assessment of agitation following traumatic brain injury. J Clin Exp Neuropsychol 1989;11:261–77.CrossRefGoogle ScholarPubMed
Cunnane, JG.Drug management of disturbed behaviour by Ppsychiatrists. Psychiatr Bull 1994;18:138–9.CrossRefGoogle Scholar
Currier, GW.Atypical antipsychotic medications in the psychiatric emergency Service. J Clin Psychiatry 2000;61(Suppl 14):21–6.Google ScholarPubMed
Currier, GW, Alien, MH.American Association for Emergency Psychiatry survey: I. Psychiatric emergency Service structure and function. Presented at the Institute on Psychiatric Services, New Orleans, Oct 29-Nov 2, 1999.Google Scholar
Currier, GW, Simpson, GM.Risperidone liquid concéntrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. J Clin Psychiatry 2001;62:153–7.CrossRefGoogle ScholarPubMed
Currier, GW, Trenton, A.Pharmacological management of psychotic agitation. CNS Drugs 2002;16:219–28.CrossRefGoogle Scholar
Daniel, DG, Potkin, SG, Reeves, KR, Swift, RH, Harrigan EP Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial. Psychopharmacology 2001; 155:128–34.CrossRefGoogle ScholarPubMed
Dawes, SS, Bloniarz, PA, Mumpower, JL, et al.Supporting psychiatric assessments in emergency rooms. Albany (NY): Center for Technology in Government; 1995Google Scholar
Donlon, PT, Hopkin, JT.Rapid “digitalization” of decompensated schizophrenic patients with antipsychotic drugs. Am J Psychiatry 1974;131:310–2.CrossRefGoogle Scholar
Donlon, PT, Hopkin, JT, Tupin, JP, et al.Haloperidol for acute schizophrenic patients: an evaluation of three oral regimens. Arch Gen Psychiatry 1980;37:691–5.CrossRefGoogle ScholarPubMed
Dubin, WR.Rapid tranquilization: antipsychotics or benzodiazepines? J Clin Psychiatry 1988;49(Suppl 12):5–11.Google ScholarPubMed
Dubin, WR, Feld, JA.Rapid tranquilization of the violent patient. Am J Emerg Med 1989;7:313–20.CrossRefGoogle ScholarPubMed
Dubin, WR, Waxman, HM, Weiss, KJ, Ramchandani, D, Tavani-Petroni, C.Rapid tranquilization: the effficacy of oral concéntrate. J Clin Psychiatry 1985;46:475–8.Google Scholar
Dubin, WR, Weiss, KJ, Dorn, JM.Pharmacotherapy of psychiatric emergencies. J Clin Psychopharmaco] 1986;6:210–22.Google ScholarPubMed
Fenton, M, Coutinho, ESF, Campbell, C.Zuclopenthixol acutate in the treatment of acute schizophrenia and similar serious mental illnesses (Cochrane review). 2002 The Cochrane library. No.3. Oxford: Update Software.Google Scholar
Forster, P.Emergency psychiatry in a new mental health system: quality versus efficiency, structures versus networks. Presented at the Sixth World Congress of the International Association of Emergency Psychiatry, Barcelona, Jun 9-12, 2002.Google Scholar
Foster, S, Kessel, J, Brman, ME, Simpson, GM.Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatnc emergency room setting. Int Clin Psychopharmacol 1997;12:175–179.CrossRefGoogle Scholar
Garza-Trevino, ES, Hollister, LE, Overall, JE, Alexander, WF.Efficacy of combinations of intramuscular antipsychotics and sedative hypnotics for control of psychotic agitation. Am J Psychiatry 1989;146:1598–601.Google ScholarPubMed
Hellewell, JSE, Cameron-Hands, D, Cantillon, M.Seroquel: evidence for efficacy in the treatment of hostility and aggression. Schizophr Res 1998;29:154–155.Google Scholar
Hillard, JR.Emergency treatment of acute psychosis. J Clin Psychiatry 1998;59(Suppl 1):57–60.Google ScholarPubMed
Huf, G, et al.Current practices in managing acutely disturbed patients at three hospitals in Rio de Janeiro-Brazil: a prevalence study. BMC Psychiatry 2002;2:4.CrossRefGoogle Scholar
Kamin, J, Manwani, S, Hughe‘s, D.Extrapyramidal side effects in the psychiatric emergency Service. Psychiatr Serv 2000;51:287–289.CrossRefGoogle ScholarPubMed
Karagianis, JL, Dawe, IC, Thakur, A, Begin, S, Raskin, J, Roychowdhury, SM, et al.Rapid tranquilization with olanzapine in acute psychosis: a case series. J Clin Psychiatry 2001;62(Suppl 2): 12–62.Google ScholarPubMed
Kay, SR, Fiszbein, A, Opler, LA.The positive and negative scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261–276.CrossRefGoogle Scholar
Kerr, IB, Taylor, D.Acute disturbed or violent behaviour: principies of treatment. J Psychopharmacol 1997;11:271–277.CrossRefGoogle ScholarPubMed
Lesem, MD, Zajecka, JM, Swift, RH, Reeves, KR, Harrigan, EP.Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients. J Clin Psychiatry 2001;62:12–18.CrossRefGoogle ScholarPubMed
Lindenmayer, JP.The pathophysiology of agitation. J Clin Psychiatry 2000;61(Suppl 14):5–10.Google ScholarPubMed
Marson, DC, McGovern, MP, Pomp, HC.Psychiatric decisión making in the emergency room: a research overview. Am J Psychiatry 1988; 145:918–25.Google ScholarPubMed
McAllister-Williams, HR, Ferrier, NI.Rapid tranquillisation: time for a reappraisal of options for parenteral therapy. Br J Psychiatry 2001;179:485–489.Google Scholar
Neborsky, R, Janowsky, D, Munson, E, et al.Rapid treatment of acute psychotic symptoms with high- and low-dose haloperidol. Arch Gen Psychiatry 1981;38:195–199.CrossRefGoogle ScholarPubMed
Overan, JE, Gorham, DR.The brief psychiatric rating scale. Psychol Rep 1962;10:799–812.Google Scholar
Pilowsky, LS, Ring, H, Shine, PJ, Battersby, M, Lader, M.Rapid tranquillisation. A survey of emergency prescribing in a general psychiatric hospital. Br J Psychiatry 1992;160:831–835.CrossRefGoogle Scholar
Raja, M, Azzoni, A.Second-generation antipsychotics in the emergency care setting. A prospective naturalistic study. Gen Hosp Psychiatry 2000;22:101–114.CrossRefGoogle ScholarPubMed
Reilly, JG, Ayis, SA, Ferrier, IN, Jones, SJ, Thomas, SH.QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 2000;355:1048–52.CrossRefGoogle ScholarPubMed
Resnick, M, Burton, BT.Droperidol vs haloperidol in the initial management of acutely agitated patients. J Clin Psychiatry 1984;45: 298–9.Google ScholarPubMed
Rothschild, AJ.Disinhibition, amnestic reactions, and other adversa reactions secondary to triazolam: a review of the literatura. J Clin Psychiatry 1992;53(12, Suppl):69–79.Google Scholar
Sallas, E, Fenton, M.Seclusion and restraint for people with serious mental illnesses (Cochrane review). 2002 The Cochrane library. No. 3. Oxford: Update Software.Google Scholar
Salzman, C, Solomon, D, Miyawaki, E, Glassman, R, Rood, L, Flowers, E, et al.Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior. J Clin Psychiatry 1991;52:177–180.Google ScholarPubMed
Sheline, Y, Nelson, T.Patient choice: deciding between psychotropic medication and physical restraints in an emergency. Bull Am Acad Psychiatry Law 1993;21:321–329.Google Scholar
Swift, RH, Harrigan, EP, Cappelleri, JC, Kramer, D, Chandler, LP.Validation of the behavioural activity rating scale (BARS)™: a novel measure of activity in agitated patients. J Psych Res 2002;36:87–95.CrossRefGoogle Scholar
Thomas, H Jr, Schwartz, E, Petrilli, R.Droperidol versus haloperidol for chemical restraint of agitated and combative patients. Ann Emerg Med 1992;21:407–413.CrossRefGoogle ScholarPubMed
Wing, J, Marriott, S, Palmer, C, Thomas, V.Management of imminent violence: clinical practice guidelines to support mental health services. Coll Psychiatrists 1998;41:1–11[Occasional paper].Google Scholar
Wright, P, Birkett, M, David, SR, Meehan, K, Ferchland, I, et al.Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry 2001;158:1149–51.CrossRefGoogle Scholar
Yudofsky, SC, Silver, JM, Jackson, W, Endicott, J, Williams, D.The overt aggression scale for the objective rating of verbal and physical aggression. Am J Psychiatry 1986;143:35–39.Google ScholarPubMed